Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Vivimed Labs Ltd

Vivimed Labs. | 532660

Market Closed
₹5.02
₹0.09 (-1.76%)
As on 22/11/26, 7:08 PM
Market Cap42.37 CR
Current Price₹5.02
High / Low₹29.4 / 4.75
PE Ratio0
Book Value₹-8.82
Dividend Yield0.00%
ROCE0.00%
ROE0.00%
Face Value₹2.00
Current Vol.63,082
Average Vol.---
ISININE526G01021
PB Ratio0
Debt to Equity0
Net Profit Margin-27.49
Operating Margin-7.43

VIVIMEDLAB - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹5.11₹5.1
₹5.02
Previous CloseToday's Open
₹4.75₹29.4
₹5.02
52W Low52W High
₹5.1Today's Open
₹5.11Previous Close
63,082Volume
₹4.7552W Low
₹29.452W High

Ratios

No data available

About Company

  • Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd
  • On April 21, 1994, the company got converted into a public limited company and the name was changed to Emgi Pharmaceuticals & Chemicals Ltd and thereafter, the Company name was finally changed to Vivimed Labs Limited on April 22, 1997
  • The Company is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations
  • The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing
  • The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc
  • The company operates in two different industry segments, namely Specialty Chemicals and Pharma Manufacturing
  • The specialty chemicals segment manufactures a range of products active ingredients for home and personal care and personal hygiene products
  • Pharmaceutical segment is engaged in contract manufacturing and job works
  • The company's portfolio has a range of specialty chemicals (active ingredients) supplied to manufacturers of beauty care products like hair care, skin care, sun care and oral care products, industrial care products, such as anti-microbial, anti-fouling agents and biocides and health care products like pharmaceutical finished drug forms for cancer, tuberculosis
  • The company's manufacturing capacities are broadly divided into: cGMP manufacturing facility located at Bidar in Karnataka State of India- capacity 250 kl per day

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI26.99
SMA 205.41
SMA 505.83
SMA 1005.73
SMA 2006.25
SMA 105.23
MACD_12_26_Days-0.25
EMA10Day5.23
EMA20Day5.43
EMA50Day5.71
MACD_12_26_9_Days-0.03
EMA100Day5.93
EMA200Day6.74

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth-22.00%
ROE0.00%
EBITDA Margin-7.43%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
116.27
149.07
187.10
237.29
861.47
Interest
2.95
2.43
35.90
39.76
53.88
Expenses
129.32
182.50
374.41
245.35
831.78
Financing Profit
-8.68
-23.45
-186.34
-6.79
39.51
Financing Margin %
-7%
-16%
-100%
-3%
5%
Other Income
4.37
9.98
0.97
1.27
9.82
Depreciation
20.22
19.94
108.41
18.28
55.50
Profit before tax
-31.85
-45.82
-330.65
-64.83
-69.86
Tax %
-0%
1%
1%
-4%
-3%
Net Profit
-31.96
-45.45
-328.54
-67.65
-71.89
EPS in Rs
-3.85
-5.48
-39.62
-8.16
-8.67
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
10 Dec 2025
EGM
EGM
17 Nov 2025
30 Sept 2025
AGM
AGM
06 Sept 2025
03 Jan 2025
AGM
AGM
11 Dec 2024
14 Aug 2024
EGM
EGM
05 Jul 2024
13 Nov 2023
AGM
AGM
18 Oct 2023
27 Mar 2023
AGM
AGM
13 Feb 2023
17 Feb 2023
AGM
AGM
13 Jan 2023

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
5
42
0
-0
0
0
-27.49%
1,885
4,52,299
37
5
30
0
19.78%
11,200
2,97,325
87
17
76
0
24.32%
4,699
1,78,727
82
10
44
1
11.09%
2,295
1,24,002
93
20
68
1
13.06%
1,195
1,19,207
26
4
18
0
9.82%
1,391
1,16,145
41
3
24
0
12.34%
1,415
1,14,312
37
3
26
0
9.92%
2,660
1,09,870
47
6
34
0
13.57%
1,795
1,03,298
25
3
17
0
10.41%
Showing 10 of 140 Results

Frequently Asked Questions

What is Share Price of Vivimed Labs Ltd?

The current share price of Vivimed Labs Ltd (Vivimed Labs.) is ₹5.02. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Vivimed Labs Ltd?

The Price-to-Earnings (P/E) ratio of Vivimed Labs Ltd is 0.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Vivimed Labs Ltd?

Vivimed Labs Ltd has a 52-week high of ₹29.40 and a 52-week low of ₹4.75. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Vivimed Labs Ltd?

Vivimed Labs Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Vivimed Labs Ltd?

The Earnings Per Share (EPS) of Vivimed Labs Ltd is ₹-21.28. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Vivimed Labs Ltd?

Vivimed Labs Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2